UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PERSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 MEDIFAST, INC. ------------------------------------------------------ (exact name of registrant as specified in its charter) DELAWARE 133714405 ------------------------ ------------------- (State of Incorporation) (I.R.S. Employer Identification No.) 11445 CRONHILL DRIVE, OWINGS MILLS, MD 21117 ---------------------------------------- ---------- (address of principal executive offices) (zip code) Securities to be registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which To be so registered each class is to be registered ------------------- ------------------------------ COMMON STOCK THE AMERICAN STOCK EXCHANGE If this form related to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A. (c), check the following box. [X] If this form related to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A. (d), check the following box. [ ] Securities Act registration statement file number to which this form relates: N/A (if applicable) ----------------- Securities to be registered pursuant to Section 12(g) of the Act: N/A INFORMATION REQUIRED IN REGISTRATION STATEMENT ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED. The American Stock Exchange has approved Medifast, Inc., to trade 11,230,881 shares of Common Stock @ a par value of $1.00 per share. As of September 30, 2002, Medifast, Inc. had 6,832,969 shares of Common Stock issued and outstanding. ITEM 2. EXHIBITS. N/A SIGNATURE Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be singed on its behalf by the undersigned, thereto duly authorized. (Registrant): /s/ BRADLEY T. MACDONALD Date: December 17, 2002 By: Bradley T. MacDonald, Chairman of the Board, Chief Executive Officer